Skip to main content

Closed

LTRN: Lantern Pharma Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

33thpctl

Volume

0.22×avg

Market Cap

33.56MUSD

P/E Ratio

-1.8TTM

Div Yield

-ann

Lantern Pharma Inc.

LTRNNASDAQ Capital Market·USD·Closed

Lantern Pharma Inc.

LTRNNASDAQ·USD·Closed

$2.63

−0.75%

$2.63

−$0.02 (0.75%)

52W Range

33thpctl

Volume

0.22×avg

Mkt Cap

33.56MUSD

P/E

-1.8TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings